Orion Animal Health receives FDA approval for Bonqat® (pregabalin oral solution)
ORION CORPORATION
PRESS RELEASE
20 NOVEMBER 2023 at 15.00 EET
Orion Animal Health receives FDA approval for Bonqat® (pregabalin oral solution)
Orion Corporation today announced that the U.S. Food and Drug Administration (FDA) has granted approval of Bonqat® (pregabalin oral solution)for alleviation of acute anxiety and fear associated with transportation and veterinary visits in cats.
Pregabalin is a new active substance for veterinary use and it acts in the central nervous system by reducing the release of various neurotransmitters (glutamate and monoaminergic neurotransmitters), resulting in an anxiolytic effect.
Orion’s long-standing strategic partner, Zoetis, has the exclusive right to market and sell Bonqat in the United States. Bonqat is anticipated to be available in the U.S. by mid-2024.
About Orion
Orion is a globally operating Finnish pharmaceutical company – a builder of well-being. We develop, manufacture and market human and veterinary pharmaceuticals and active pharmaceutical ingredients. Orion has an extensive portfolio of proprietary and generic medicines and self-care products. The core therapy areas of our pharmaceutical R&D are oncology and pain. Proprietary products developed by Orion are used to treat cancer, neurological diseases and respiratory diseases, among others. Orion's net sales in 2022 amounted to EUR 1,341 million and the company had about 3,500 employees at the end of the year. Orion's A and B shares are listed on Nasdaq Helsinki.
About Zoetis
As the world’s leading animal health company, Zoetis is driven by a singular purpose: to nurture our world and humankind by advancing care for animals. After innovating ways to predict, prevent, detect, and treat animal illness for more than 70 years, Zoetis continues to stand by those raising and caring for animals worldwide – from veterinarians and pet owners to livestock farmers and ranchers. The company’s leading portfolio and pipeline of medicines, vaccines, diagnostics and technologies make a difference in over 100 countries. A Fortune 500 company, Zoetis generated revenue of $8.1 billion in 2022 with approximately 13,800 employees. For more information, visit www.zoetis.com.
Contact person:
Tuukka Hirvonen, Investor Relations
Orion Corporation
tel. +358 10 426 2721
e-mail: tuukka.hirvonen@orion.fi
Publisher:
Orion Corporation
Communications
Orionintie 1A, FI-02200 Espoo, Finland
www.orion.fi
To view this piece of content from www.globenewswire.com, please give your consent at the top of this page.
To view this piece of content from ml-eu.globenewswire.com, please give your consent at the top of this page.
About GlobeNewswire by notified
GlobeNewswire by notifiedGlobeNewswire by notified is one of the world's largest newswire distribution networks, specializing in the delivery of corporate press releases financial disclosures and multimedia content to the media, investment community, individual investors and the general public.
Subscribe to releases from GlobeNewswire by notified
Subscribe to all the latest releases from GlobeNewswire by notified by registering your e-mail address below. You can unsubscribe at any time.
Latest releases from GlobeNewswire by notified
Wistar Scientists Identify Esophageal Cancer Biomarkers6.12.2023 16:09:10 CET | Press release
Dr. Noam Auslander and authors trained a neural network to identify cancer risk from microbes Philadelphia, PA, Dec. 06, 2023 (GLOBE NEWSWIRE) -- Wistar scientists have developed a new tool that can help identify cancer-associated microbes by using machine learning technology. Under the leadership of Dr. Noam Auslander — assistant professor in the Ellen and Ronald Caplan Cancer Center’s Molecular & Cellular Oncogenesis Program — the group has analyzed short read RNA-sequencing data to detect biomarkers for esophageal carcinoma, or ESCA. Their paper, “Microbial gene expression analysis of healthy and cancerous esophagus uncovers bacterial biomarkers of clinical outcomes,” was published in International Society for Microbial Ecology Communications. Tumor microenvironments are often analyzed using RNA sequencing, or RNAseq, which identifies mRNA in a population of cells to find which genes are being expressed. Theoretically, RNAseq data can reveal the expression of microbial genes in canc
The Cadmium Yellow Alert: Study Explains the Rapid Deterioration of One of Juan Mirò’s Favourite Colours6.12.2023 15:57:37 CET | Press release
Researchers from the Politecnico di Milano and Ca' Foscari University of Venice are part of the team unravelling the causes of the degradation of cadmium yellow, used by the Spanish painter: the presence of zinc in the crystalline matrix of the pigment, the production process and the environmental conditions in which paint was stored. The research is published in the scientific journal Heritage Science. MILAN, Italy, Dec. 06, 2023 (GLOBE NEWSWIRE) -- A photo from 1978 shows famous Catalan surrealist painter Juan Miró in his Taller Sert, surrounded by his paintings. In the background, the bright, intense yellow of Femme dans le rue (1973), stands out. Fifty years later, that cadmium-based yellow is faded and chalky. The same phenomenon has affected 25 other paintings in the Fundació Miró Mallorca. The degraded yellow paint used by Mirò is made from cadmium yellow, a modern pigment composed of cadmium sulfide and introduced in the late 19th century. The pigment was used extensively by ar
Baltic Horizon Fund general meeting of investors and a notice to convene a new general meeting of investors6.12.2023 15:20:00 CET | Press release
Extraordinary General Meeting (hereinafter the “General Meeting”) of Baltic Horizon Fund unit-holders and Swedish Depositary Receipt (hereinafter the “SDR”) holders (hereinafter together the “Investors”) took place on 6 December 2023 in Tallinn, Estonia. Proposed agenda of the meeting was the following: Decision to elect Reimo Hammerberg as a new member of the supervisory board of Baltic Horizon Fund as of 1 January 2024 for an indefinite period.Decision to pay remuneration to Reimo Hammerberg for fulfilling obligations of the member of the supervisory board in the amount of EUR 16,000 per calendar year.Decision to elect Monica Hammer as a new member of the supervisory board of Baltic Horizon Fund as of 1 January 2024 for an indefinite period.Decision to pay remuneration to Monica Hammer for fulfilling obligations of the member of the supervisory board in the amount of EUR 11,000 per calendar year.Decision to elect Per V. Jenster as a new member of the supervisory board of Baltic Horiz
Vicinity Showcased Industrial 5G Solution in 5G-ACIA Industrial 5G day6.12.2023 15:08:22 CET | Press release
TAIPEI, Taiwan, Dec. 06, 2023 (GLOBE NEWSWIRE) -- Vicinity Technologies Limited (Vicinity) showcases the advanced industrial 5G solution in the 5G Alliance for Connected Industries and Automation (5G-ACIA) Industrial 5G Day 2023, being held in Taipei, Taiwan on 7th December 2023. Vicinity is demonstrating a low latency industrial 5G wireless networking solution to enable industrial safety applications in factories with 5G connected Automatic Guided Vehicles (AGV). Vicinity developed 5G integrated small cell (ISC) network wirelessly connects an emergency stop controller with the AGVs. The demonstration emulates an emergency scenario where the stop button is activated. The AGVs are stopped with the latency within 3ms. The response time is 200 times faster compared with the conventional 5G mobile networks. To achieve such a fast response time, the ISC supports the User Plane Function (UPF) offloading. This allows the user application running on the ISC to minimise the latency. The ISC is
International Directional Services and Veracio Announce Strategic Partnership to Advance Drilling and Downhole Technologies in North America6.12.2023 15:00:00 CET | Press release
WATSONVILLE, Calif. and SALT LAKE CITY, Dec. 06, 2023 (GLOBE NEWSWIRE) -- International Directional Services (IDS), a Granite Company (NYSE:GVA) and Veracio, a leading mining technology company, today announce a partnership to offer Veracio’s complete suite of driller-operated tooling to IDS’ clients. Veracio is making significant steps toward leveraging advanced geological technologies to enhance the mining lifecycle. While IDS and Veracio have an existing relationship, the announcement of this partnership acknowledges the vision both companies share for transforming how the drilling workflow can be enhanced with better data. By combining IDS’s expertise in directional drilling and Veracio’s geological data collection, the partnership will empower IDS and Granite clients to reduce unnecessary drilling costs, mitigate operational errors, minimize waste, and foster sustainable mining practices. “Our collaboration further strengthens Veracio’s position in the US market and reinforces our